News for Leica SCN400

Extra-large double and jumbo slide scanning capabilities in the Leica SCN400 digital slide scanner range

Double and Jumbo Slide Scanning on the Leica SCN400

Wetzlar, Germany. The largest capture area of any line scanner in digital pathology is now possible with the Leica SCN400 and SCN400 F. The latest release in Leica’s Total Digital Pathology portfolio enables the digitization of very large specimens, not possible with any other line scanning digital pathology system.

This development provides a new level of flexibility in digital pathology, enabling users to scan a wide range of samples on a single system. Traditional (26 x 76 mm), double (52 x 76 mm) and now extra-large Jumbo (113 x 76 mm) slides can all be captured in either brightfield or fluorescence using the Leica SCN400 and SCN400 F scanners.

Existing users of the Leica SCN400 digital slide scanner range can benefit from being able to implement large slide scanning, without any hardware changes or physical updates to their scanners.

To view some sample large slide scans, please visit our Virtual Slide Gallery at www.leica-microsystems.com/products/digital-pathology.

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems says, “Line scanning in digital pathology has, until now, been limited to single and double slides. The introduction of extra-large slide scanning is a significant advancement for neuroscience, toxicological pathology and anyone dealing with large tissue sections. The cost and time saving benefits of sharing large tissue sections digitally rather than physically is a valuable tool for our users.”

Leica Microsystems’ Total Digital Pathology portfolio scanning range enables the capture of the widest range of sample types whether brightfield, fluorescence or FISH demon­strating Leica’s drive and innovation in this market. Leica Microsystems’ broad range of interoperable Digital Pathology components provides customers with the flexibility to choose the solution that is right for their needs.

Experience Leica Microsystems’ Total Digital Pathology solutions at booth 2825 during the Society for Neuroscience annual meeting, from November 12-16 in Washington, DC.

• Press Release Leica Jumbo Slide (English)
• Press Release Leica Jumbo Slide (German)

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

Access and review the high resolution scans via internet, using Leica Microsystems’ digital pathology software, SlidePath Digital SlideBox

Bringing Digital Pathology Excellence to the Hematopathology Workshop

Wetzlar, Germany / Los Angeles, USA. Leica Microsystems, world-leading providers of Total Digital Pathology solutions, are a proud platinum sponsor of this year’s joint workshop of the Society for Hematopathology and the European Association for Haematopathology (SH/EAHP) being held at the Ritz-Carlton Marina Del Rey, Los Angeles, USA, from October 27-29, 2011.

With a record number of case submissions and registered delegates, this year’s SH/EAHP Workshop promises to be an exciting meeting for physicians who are interested in the field of “Cutaneous Lymphomas and Their Mimics”, the topic of the Workshop. In addition to an impressive agenda of presentations from world-leading experts, attendees of the Workshop will be able to access cases for review online before, during and after the meeting.

From over 300 cases submitted to the Workshop, 120 have been selected by the Workshop Panel for inclusion in the Workshop Book. Attendees will be able to access scanned slides of these 120 cases via the internet using Leica Microsystems’ digital pathology educational software, SlidePath Digital SlideBox. The scanned images are high resolution scans of the whole glass slides generated using the Leica SCN400. Furthermore, the Workshop attendees can view PowerPoint and Word documents files of all submitted and accepted cases on the Workshop Case Server, providing rich content for the Workshop discussions.

The Workshop attendees with iPads will be able to access and review the high resolution scans of the glass slides through Leica Microsystems’ digital pathology application, SlidePath Gateway.

Dr. Sophie Song, Organizing Committee Chair, SH/EAHP Workshop 2011 says, “We are very happy to have Leica Microsystems as one of our platinum sponsors for this event. The image quality of the Leica SCN400 scanned slides coupled with the ease of use of Digital SlideBox makes Leica’s Total Digital Pathology system ideal for supporting our workshop. Attendees will really benefit from being able to readily access the cases, either through their internet browser or on the iPad.”

Registered attendees will receive information on how to access the Workshop Case Server through both Digital SlideBox and the iPad.

For non-attendees, sample images of the Leica SCN400 digital slide scanner can be seen in the Virtual Slide Gallery at www.leica-microsystems.com/products/digital-pathology/ or by downloading SlidePath Gateway from the Apple app store.

• Press Release Platinum Sponsor SH/EAHP Workshop (English)
• Press Release Platinum Sponsor SH/EAHP Workshop (German)

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

Comprehensive Digital Pathology Scanning and Analysis Solutions

Comprehensive Digital Pathology Scanning and Analysis Solutions

Wetzlar, Germany / Hørsholm, Denmark. Leica Microsystems, world-leading providers of Total Digital Pathology solutions, and Visiopharm the leading provider of Histoinformatics Solutions for Life-Sciences, today announce the completed integration of Leica’s SlidePath Digital Image Hub with Visiopharm’s Whole-Slide Informatics™ solutions for Digital Pathology. Users can now take advantage of superior image capture and management from Leica Microsystems and excellent Whole Slide image analysis and Whole Slide Stereology from Visiopharm in a single system.

This integration provides a truly streamlined workflow for customers using image analysis and stereology in digital pathology. All images stored on the Digital Image Hub server can be browsed and accessed via the Visiopharm software. Selected images are then easily opened and analyzed by either Visiopharm’s image analysis software or stereology software. Following analysis, users can quickly view the resulting data and associated slides through the Visiopharm software interface.

Leica’s Digital Image Hub, developed by SlidePath, is a scalable enterprise-level solution for the management and archiving of digital slides and associated data. As Digital Image Hub is accessed via a standard internet browser and supports images from a variety of digital slide scanners, it is the perfect partner for Visiopharm’s whole slide analysis solutions.

Stavanger University Hospital have chosen Leica Microsystems’ Total Digital Pathology solution for scanning and storage of digital slides, and the Visiopharm solution for image analysis.

Dr. Kjell H Kjellevold, Head of the Pathology Department says, “For us, the combination of these two systems is ideal. The speed and image quality of the Leica SCN400 slide scanner combined with the Digital Image Hub management solution is exactly what is required for making Digital Pathology feasible for research work. The image analysis software from Visiopharm consolidates simplicity for routine work and the flexibility for research. This, together with the low costs of learning and computation, was critical for our decision”.

While Leica Microsystems will continue to develop and expand their existing range of Digital Pathology image analysis solutions, including Tissue IA and the Ariol system, the integration with Visiopharm gives additional options to customers, enabling them to choose the analysis solution that is right for their needs.

Visiopharm will continue to consolidate and expand its integration to the leading slide databases on the Digital Pathology market.

• Press Release Leica Visiopharm (English)
• Press Release Leica Visiopharm (German)

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

Visiopharm provides advanced analysis software for digital pathology.

The Whole Slide Informatics™ platform from Visiopharm® combines image analysis and stereology on the same software platform, making it possible to obtain valid and unbiased quantitative data both in the 2- and 3- dimensional space by analysis of planar tissue sections.

The image analysis tools VisiomorphDP and TissuemorphDP provides solutions for both clinical and pre-clinical research applications with flexibility, robustness, and low computational costs even for complex analysis. With a novel approach to setting up image analysis protocols, typical image analysis problems such as quantifying nuclear, membrane, and cytoplasmic markers, can be addressed effectively with just a few hours of training.

Visiopharm’s patented Whole Slide Stereology solutions automates time-consuming parts of the classical stereology methods helping the researcher to perform stereological analysis significantly faster and more efficient than with classical stereology.

Our software solutions are designed to operate on all major scanner brands on the market and a wide variety of classical microscopes.

Visiopharm is a privately owned company. The headquarters is located in Medicon Valley, Denmark, one of the strongest bio-regions in Europe. For more information please visit: www.visiopharm.com

In this presentation Olga Colgan will address the use of Digital Pathology as a tool to accelerate progress in biomarker discovery and validation in the Pharma / CRO domain.

Download the fourth webinar of our Digital Pathology webinar series where we address the use of the Leica SCN400 and software suite for Pharma Research.

• Register to Download

With the growing adoption of whole slide imaging solutions in pharmaceutical research, Leica Microsystems provides a flexible suite of solutions to address these needs.  Both FISH and brightfield scanning will be addressed in addition to intuitive management workflows and tools for quantitative biomarker expression in whole slide and TMA analysis. 

SlidePath Gateway provides access to high quality whole slide images captured on the Leica SCN400 slide scanner

SlidePath Gateway is Available for Download

Wetzlar, Germany. Leica Microsystems announces the release of the SlidePath Gateway application for iPad and iPhone, which is the latest addition to the Total Digital Pathology portfolio. SlidePath Gateway is a Digital Pathology viewing application with built-in educational content from leading institutes and pathologists. The free application is available now for download from the Apple App store.

SlidePath Gateway provides access to high quality whole slide images captured on the Leica SCN400 slide scanner, with expert review findings and content provided by contributing bodies including:

• ASCP CheckPath Anatomical Pathology EQA Program (2006)
• Cerviva Cervical Cytology EQA Pilot (2009)
• NHS Breast Screening Pathology EQA Program (2010)
• UK National Urologic Pathology EQA Program (2009)
• UKNEQAS HER2 Breast Interpretive EQA Pilo (2011)

Dr. Donal O’Shea, Head of Digital Pathology in Leica Microsystems says, “The release of the SlidePath Gateway App displays Leica Microsystems’ commitment to develop and expand its Digital Pathology portfolio. With this App we are giving everyone the opportunity to try Digital Pathology, access high resolution whole slide images and expert opinions, through a highly intuitive user interface. With the rapid adoption and acceptance of iPads and other tablet devices in hospitals and clinical settings, we see SlidePath Gateway paving the way for future adoption of Digital Pathology in routine use.”

SlidePath Gateway for the iPad puts Digital Pathology at your fingertips. Users who install the application can browse folders of images from each of the External Quality Assessment (EQA) programs, select individual cases and view, zoom and navigate around the slides. Each case includes expert pathologist assessments, which can be viewed with the slides, giving increased insight into the samples. They can also see a sample set of Leica Biosystems’ Novocastra antibody range.

Existing users of Leica Microsystems’ Digital Pathology management solution, SlidePath Digital Image Hub (DIH), who usually access their system via a standard internet browser, can now securely connect to their own DIH library of images and review them through the application.

Building on a strong reputation for providing high quality, easy-to-use systems, SlidePath Gateway demonstrates Leica’s drive to deliver cutting edge, flexible tools to the Digital Pathology market.

• Press Release Leica SlidePath Gateway (English)
• Press Release Leica SlidePath Gateway (German)

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company’s history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems’ tradition of innovation, which draws on users’ ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems’ Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.